In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Update Commission Regulation regarding monacolins from red yeast rice

Update Commission Regulation regarding monacolins from red yeast rice

by In2Pharma | Jul 5, 2022 | News

Europe The Commission Regulation (EU) 2022/860 amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards monacolins from red yeast rice has been published on 2nd June 2022. This Regulation entered into force on 22nd...

Recent Posts

  • Reminder – update RD pregabalin/gabapentin
  • Updated deontological code animal health pharma.be
  • Cover letter variation submission
  • IML Updates Code of Ethics and Hospitality Thresholds
  • Guidance FAMHP on premiums and benefits

Follow Us

  • Facebook
  • LinkedIn
An IQVIA Business

IQVIA Logo
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.

www.iqvia.com

Contact Us

Privacy Policy | Your Privacy Choices | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com |Terloonststraat 22, 1910 Kampenhout, België